Moreover, Peng et al found that reduced EPHB6 levels are associated with advanced disease stage35, suggesting that the levels of EPHB6 may not be an independent prognostic factor for patients with colorectal cancer. This evidence concerns the gene EPHB6 and colorectal cancer.